Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancerReportar como inadecuado




Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 9:87

First Online: 21 March 2009Received: 28 September 2008Accepted: 21 March 2009DOI: 10.1186-1471-2407-9-87

Cite this article as: Fujita, T., Ikeda, H., Taira, N. et al. BMC Cancer 2009 9: 87. doi:10.1186-1471-2407-9-87

Abstract

BackgroundUbcH10 participates in proper metaphase to anaphase transition, and abrogation of UbcH10 results in the premature separation of sister chromatids. To assess the potential role of UbcH10 in colon cancer progression, we analyzed the clinicopathological relevance of UbcH10 in colon cancer.

MethodsWe firstly screened the expression profile of UbcH10 in various types of cancer tissues as well as cell lines. Thereafter, using the colon cancer cells line, we manipulated the expression of UbcH10 and evaluated the cell cycle profile and cellular proliferations. Furthermore, the clinicopathological significance of UbcH10 was immunohistologically evaluated in patients with colon cancer. Statistical analysis was performed using the student-s t-test and Chi-square test.

ResultsUsing the colon cancer cells, depletion of UbcH10 resulted in suppression of cellular growth whereas overexpression of UbcH10 promoted the cellular growth and oncogenic cellular growth. Mitotic population was markedly alternated by the manipulation of UbcH10 expression. Immunohistochemical analysis indicated that UbcH10 was significantly higher in colon cancer tissue compared with normal colon epithelia. Furthermore, the clinicopathological evaluation revealed that UbcH10 was associated with high-grade histological tumors.

ConclusionThe results show the clinicopathological significance of UbcH10 in the progression of colon cancer. Thus UbcH10 may act as a novel biomarker in patients with colon cancer.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2407-9-87 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Autor: Takeo Fujita - Hirokuni Ikeda - Naruto Taira - Shinji Hatoh - Minoru Naito - Hiroyoshi Doihara

Fuente: https://link.springer.com/







Documentos relacionados